CDKN2C and prostate cancer: To further investigate the molecular mechanism underlying cell cycle arrest, we examined the effect of TA treatment on cell cycle regulatory proteins (cell cycle inhibitory proteins (p21INK4C and p18INK4C) and cyclin D1) in prostate cancer cells.